Bunglawala, Fazila
12  results:
Search for persons X
?
4

The LEAP Process: Streamlining the Development of Long-Acti..:

Flexner, Charles ; Siccardi, Marco ; Bunglawala, Fazila.
Clinical Infectious Diseases.  75 (2022)  Supplement_4 - p. S502-S509 , 2022
 
?
7

Prediction of dolutegravir pharmacokinetics and dose optimi..:

Siccardi, Marco ; Owen, Andrew ; Mirochnick, Mark..
Journal of Antimicrobial Chemotherapy.  75 (2019)  3 - p. 640-647 , 2019
 
?
9

Tuning the Binding Affinity and Selectivity of Perfluoroary..:

Verhoork, Sanne J. M ; Jennings, Claire E ; Rozatian, Neshat...
Verhoork , S J M , Jennings , C E , Rozatian , N , Reeks , J , Meng , J , Corlett , E K , Bunglawala , F , Noble , M E M , Leach , A G & Coxon , C R 2019 , ' Tuning the Binding Affinity and Selectivity of Perfluoroaryl-Stapled Peptides by Cysteine-Editing ' , Chemistry-A European Journal , vol. 25 , no. 1 , pp. 177-182 . https://doi.org/10.1002/chem.201804163.  , 2019
 
?
11

PBPK Modelling of Dexamethasone in Patients With COVID-19 a..:

Maiara Camotti Montanha ; Nicolas Cottura ; Michael Booth...
https://www.frontiersin.org/articles/10.3389/fphar.2022.814134/full.  , 2022
 
?
12

DataSheet1_PBPK Modelling of Dexamethasone in Patients With..:

Maiara Camotti Montanha (12013826) ; Nicolas Cottura (12013829) ; Michael Booth (560363)...
https://figshare.com/articles/dataset/DataSheet1_PBPK_Modelling_of_Dexamethasone_in_Patients_With_COVID-19_and_Liver_Disease_DOCX/19086536.  , 2022
 
1-12